FH Messerli - Annals of internal medicine, 2003 - Am Coll Physicians The recent Antihypertensive and Lipid-Lowering Treatment to Pre- vent Heart Attack Trial
(ALLHAT) showed that the primary end point, coronary heart disease, was identical in the
chlorthalidone, lisinopril, and amlodipine groups. Yet the major conclusion of this trial was ... Cited by 39 - Related articles - BL Direct - All 5 versions
A Zanchetti, G Mancia - Journal of hypertension, 2003 - journals.lww.com The recent publication of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart
Attack Trial (ALLHAT) trial results has prompted the Editors of the Journal of Hypertension to
invite commentaries from respected experts from various parts of the world. We believe ... Cited by 17 - Related articles - BL Direct - All 3 versions
- ►annals.org [PDF] BR Davis, CD Furberg, JT Wright Jr, JA … - Annals of internal …, 2004 - Am Coll Physicians The findings of the Antihypertensive and Lipid-Lowering Treat- ment to Prevent Heart Attack
Trial (ALLHAT) have generated worldwide reaction from clinicians and researchers, including
a recent commentary in this journal. Such response was expected for a trial of ALLHAT's ... Cited by 43 - Related articles - All 12 versions
HA Punzi, CF Punzi - Current Hypertension Reports, 2004 - Springer Many studies have documented the benefit for stroke reduction in antihypertensive therapy, but
review of these trials demonstrates that the reduction in coronary heart disease (CHD) event
rates were less than expected [2]. One assumption for this discrepancy in outcomes of ... Cited by 15 - Related articles - BL Direct - All 3 versions
JD Guo, GG Liu, DB Christensen, AZ Fu - Value in Health, 2003 - interscience.wiley.com Background:The US Joint National Committee (JNC) on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure issues guidelines on the optimal first-line drug therapy in treating
hypertension. Despite broad dissemination of these guidelines, prescribing practices ... Cited by 18 - Related articles - BL Direct - All 3 versions
[CITATION] Angiotensin II alters neurovascular coupling via production of reactive oxygen …
MS Player, JM Gill, HB Fagan, AG Mainous III - J Clin Hypertens, 2006 - interscience.wiley.com This national study examines the impact of the Antihypertensive and Lipid-Lowering Treatment
to Prevent Heart Attack Trial (ALLHAT) on the prescribing of thiazide-type diuretics and other
antihypertensive medications for patients with newly diagnosed hypertension. A cross- ... Cited by 6 - Related articles - BL Direct - All 5 versions
- ►ahajournals.org RS Stafford, V Monti, CD Furberg, J Ma - Hypertension, 2006 - Am Heart Assoc Medication choices for the treatment of elevated blood pressure have a large potential impact
on both patient outcomes and health care costs. Historic trends of prescribing for hypertension
will advance the understanding of physician practice of evidence-based medicine. This ... Cited by 33 - Related articles - All 6 versions
- ►ahajournals.org J Ma, KV Lee, RS Stafford - Hypertension, 2006 - Am Heart Assoc Monitoring national patterns of antihypertensive drug therapy is essential to assessing adherence
to treatment guidelines and the impact of major scientific publications on physician
prescribing. We analyzed data from 2 US National Ambulatory Care Surveys to examine ... Cited by 29 - Related articles - All 5 versions
MA Weber - The Journal of clinical hypertension(Greenwich, Conn.), 2003 - cat.inist.fr The ALLHAT report: A case of information and misinformation. Michael A WEBER The Journal
of clinical hypertension(Greenwich, Conn.) 5:11, 9-13, Le Jacq Communications, 2003.
Cited by 50 - Related articles - BL Direct - All 3 versions
